Global Bioanalytical Testing Services Market

Bioanalytical Testing Services Comprehensive Study by Type (Cell Based Assays (Bacterial, Viral), Virology Testing (In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays), Serology, Immunogenicity & Neutralizing Antibodies (Bacterial, Viral), Toxicology Services (In-Vitro Toxicology, In-Vivo Toxicology, Others), Biomarker Testing, Metabolic Profiling and Mass Balance Studies, Method Development Optimization and Validation, Pharmacokinetic Testing, Other Services), Application (Oncology, Immunology, Neurology, Hematology, Others), End User (Biopharmaceutical Companies, Contract Development and Manufacturing Organization, Clinical Research Organizations/Contract Research Organizations), Molecule Type (Small Molecule, Large Molecule (LC-MS Studies, Immunoassays, Others)) Players and Region - Global Market Outlook to 2026

Bioanalytical Testing Services Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 12.61%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Bioanalytical testing services refers to analytical method used for the analysis of biological products for drug development, commercialization of drugs, and drug discovery at clinical or preclinical stage. The uses of this testing method are in bioavailability, pharmacology, studies of toxicology and various others to determine drug quantity while leaving out quality parameters. Considering the need for early disease detection amid rise in number of chronic diseases, bioanalysis becomes important which attracted huge investment in its developments of late. Further, Bioanalytical testing services market has high growth prospects owing to increasing number of patients with chronic diseases. For instance, according to World Health Organization (WHO) cancer is the second leading cause of death and led to 9.6 million deaths globally in 2018.
According to AMA, the market for Bioanalytical Testing Services is expected to register a CAGR of 12.61% during the forecast period to 2026. This growth is primarily driven by Growth in the Biopharmaceutical Industry and Increasing Adoption of Outsourcing R&D Activities by the Pharmaceutical Companies.

Globally, a noticeable market trend is evident Emphasizing On Liquid Chromatography-Mass Spectrometry [LC/MS/MS] Analytical Technique for Performing Bioanalytical Testing . The Health Care Services sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Charles River Laboratories International Inc. (United States), BioReliance Corporation (United States), WuXi PharmaTech (Cayman) Inc. (China), Bioclin Research Laboratories (Ireland), Eurofins Scientific SE (Luxembourg), SGS (Switzerland), Merck Group (Germany), LabCorp (United States), PPD Inc. (United States), Bioanalytical Technologies Private Limited (India), Intertek Group Plc. (United Kingdom), PRA Health Sciences (United States) and Parexel International (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
2nd November 2018, Eurofins Scientific SE a bioanalytical testing provider acquired Test America the environmental testing laboratory in the United States and EnvironeX Group Inc. engaged in laboratory analyses for the health and pharmaceutical sectors in Canada to expands its bioanalytical testing capabilities in the North American market.
In 2018 SGS SA, a biopharmaceutical analytical and bioanalytical contract solutions provider invested USD 3.94 million in a new two phase expansion project at its laboratory in Poitiers, France to expand their bioanalytical testing capabilities.

Regulatory Insights:
“In the FDA Guidance for Industry: Bioanalytical Method Validation, FDA clearly stated that: ‘the bioanalytical method for human BA, BE, PK, and drug interaction studies must meet the criteria in 21 CFR 320.29. The analytical laboratory should have a written set of standard operating procedures (SOPs) to ensure a complete system of quality control and assurance. The SOPs should cover all aspects of analysis from the time the sample is collected and reaches the laboratory until the results of the analysis are reported. The SOPs also should include the record keeping, security and chain of sample custody (accountability systems that ensure integrity of test articles), sample preparation, and analytical tools such as methods, reagents, equipment, instrumentation, and SOPs for quality control and verification of results.”

Market Drivers
  • Growth in the Biopharmaceutical Industry
  • Increasing Adoption of Outsourcing R&D Activities by the Pharmaceutical Companies

Market Trend
  • Emphasizing On Liquid Chromatography-Mass Spectrometry [LC/MS/MS] Analytical Technique for Performing Bioanalytical Testing
  • Increasing Demand for Bioanalytical Testing For Large-Molecule Drugs

Restraints
  • High Prize Associated With Bioanalytical Testing Services
  • Lack of Skilled Professionals to Adopt New Technology

Opportunities
Advancement in the Combination Molecules, Identical Biological Drugs, and Innovative Medicines Owing to High Prevalence of Chronic Diseases and Increasing Demand for Outsourcing Services for Healthcare from Developing Economies
Challenges
Lack of Advance Healthcare Infrastructure in Emerging Countries

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Bioanalytical Testing Services Study Sheds Light on
— The Bioanalytical Testing Services Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Bioanalytical Testing Services industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Bioanalytical Testing Services industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Cell Based Assays [Bacterial, Viral]
  • Virology Testing [In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays]
  • Serology, Immunogenicity & Neutralizing Antibodies [Bacterial, Viral]
  • Toxicology Services [In-Vitro Toxicology, In-Vivo Toxicology, Others]
  • Biomarker Testing
  • Metabolic Profiling and Mass Balance Studies
  • Method Development Optimization and Validation
  • Pharmacokinetic Testing
  • Other Services
By Application
  • Oncology
  • Immunology
  • Neurology
  • Hematology
  • Others
By End User
  • Biopharmaceutical Companies
  • Contract Development and Manufacturing Organization
  • Clinical Research Organizations/Contract Research Organizations

By Molecule Type
  • Small Molecule
  • Large Molecule [LC-MS Studies, Immunoassays, Others]

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • Russia
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in the Biopharmaceutical Industry
      • 3.2.2. Increasing Adoption of Outsourcing R&D Activities by the Pharmaceutical Companies
    • 3.3. Market Challenges
      • 3.3.1. Lack of Advance Healthcare Infrastructure in Emerging Countries
    • 3.4. Market Trends
      • 3.4.1. Emphasizing On Liquid Chromatography-Mass Spectrometry [LC/MS/MS] Analytical Technique for Performing Bioanalytical Testing
      • 3.4.2. Increasing Demand for Bioanalytical Testing For Large-Molecule Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Bioanalytical Testing Services, by Type, Application, End User , Molecule Type and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Bioanalytical Testing Services (Value)
      • 5.2.1. Global Bioanalytical Testing Services by: Type (Value)
        • 5.2.1.1. Cell Based Assays [Bacterial, Viral]
        • 5.2.1.2. Virology Testing [In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays]
        • 5.2.1.3. Serology, Immunogenicity & Neutralizing Antibodies [Bacterial, Viral]
        • 5.2.1.4. Toxicology Services [In-Vitro Toxicology, In-Vivo Toxicology, Others]
        • 5.2.1.5. Biomarker Testing
        • 5.2.1.6. Metabolic Profiling and Mass Balance Studies
        • 5.2.1.7. Method Development Optimization and Validation
        • 5.2.1.8. Pharmacokinetic Testing
        • 5.2.1.9. Other Services
      • 5.2.2. Global Bioanalytical Testing Services by: Application (Value)
        • 5.2.2.1. Oncology
        • 5.2.2.2. Immunology
        • 5.2.2.3. Neurology
        • 5.2.2.4. Hematology
        • 5.2.2.5. Others
      • 5.2.3. Global Bioanalytical Testing Services by: Molecule Type (Value)
        • 5.2.3.1. Small Molecule
        • 5.2.3.2. Large Molecule [LC-MS Studies, Immunoassays, Others]
      • 5.2.4. Global Bioanalytical Testing Services Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. Russia
          • 5.2.4.3.3. France
          • 5.2.4.3.4. Italy
          • 5.2.4.3.5. United Kingdom
          • 5.2.4.3.6. Netherlands
          • 5.2.4.3.7. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Bioanalytical Testing Services (Price)
      • 5.3.1. Global Bioanalytical Testing Services by: Type (Price)
  • 6. Bioanalytical Testing Services: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Charles River Laboratories International Inc. (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. BioReliance Corporation (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. WuXi PharmaTech (Cayman) Inc. (China)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Bioclin Research Laboratories (Ireland)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Eurofins Scientific SE (Luxembourg)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. SGS (Switzerland)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Merck Group (Germany)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. LabCorp (United States)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. PPD Inc. (United States)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. Bioanalytical Technologies Private Limited (India)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
      • 6.1.11. Intertek Group Plc. (United Kingdom)
        • 6.1.11.1. Business Overview
        • 6.1.11.2. Products/Services Offerings
        • 6.1.11.3. Financial Analysis
        • 6.1.11.4. SWOT Analysis
      • 6.1.12. PRA Health Sciences (United States)
        • 6.1.12.1. Business Overview
        • 6.1.12.2. Products/Services Offerings
        • 6.1.12.3. Financial Analysis
        • 6.1.12.4. SWOT Analysis
      • 6.1.13. Parexel International (United States)
        • 6.1.13.1. Business Overview
        • 6.1.13.2. Products/Services Offerings
        • 6.1.13.3. Financial Analysis
        • 6.1.13.4. SWOT Analysis
  • 7. Global Bioanalytical Testing Services Sale, by Type, Application, End User , Molecule Type and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Bioanalytical Testing Services (Value)
      • 7.2.1. Global Bioanalytical Testing Services by: Type (Value)
        • 7.2.1.1. Cell Based Assays [Bacterial, Viral]
        • 7.2.1.2. Virology Testing [In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays]
        • 7.2.1.3. Serology, Immunogenicity & Neutralizing Antibodies [Bacterial, Viral]
        • 7.2.1.4. Toxicology Services [In-Vitro Toxicology, In-Vivo Toxicology, Others]
        • 7.2.1.5. Biomarker Testing
        • 7.2.1.6. Metabolic Profiling and Mass Balance Studies
        • 7.2.1.7. Method Development Optimization and Validation
        • 7.2.1.8. Pharmacokinetic Testing
        • 7.2.1.9. Other Services
      • 7.2.2. Global Bioanalytical Testing Services by: Application (Value)
        • 7.2.2.1. Oncology
        • 7.2.2.2. Immunology
        • 7.2.2.3. Neurology
        • 7.2.2.4. Hematology
        • 7.2.2.5. Others
      • 7.2.3. Global Bioanalytical Testing Services by: Molecule Type (Value)
        • 7.2.3.1. Small Molecule
        • 7.2.3.2. Large Molecule [LC-MS Studies, Immunoassays, Others]
      • 7.2.4. Global Bioanalytical Testing Services Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. Russia
          • 7.2.4.3.3. France
          • 7.2.4.3.4. Italy
          • 7.2.4.3.5. United Kingdom
          • 7.2.4.3.6. Netherlands
          • 7.2.4.3.7. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Bioanalytical Testing Services (Price)
      • 7.3.1. Global Bioanalytical Testing Services by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bioanalytical Testing Services: by Type(USD Billion)
  • Table 2. Bioanalytical Testing Services Cell Based Assays [Bacterial, Viral] , by Region USD Billion (2015-2020)
  • Table 3. Bioanalytical Testing Services Virology Testing [In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays] , by Region USD Billion (2015-2020)
  • Table 4. Bioanalytical Testing Services Serology, Immunogenicity & Neutralizing Antibodies [Bacterial, Viral] , by Region USD Billion (2015-2020)
  • Table 5. Bioanalytical Testing Services Toxicology Services [In-Vitro Toxicology, In-Vivo Toxicology, Others] , by Region USD Billion (2015-2020)
  • Table 6. Bioanalytical Testing Services Biomarker Testing , by Region USD Billion (2015-2020)
  • Table 7. Bioanalytical Testing Services Metabolic Profiling and Mass Balance Studies , by Region USD Billion (2015-2020)
  • Table 8. Bioanalytical Testing Services Method Development Optimization and Validation , by Region USD Billion (2015-2020)
  • Table 9. Bioanalytical Testing Services Pharmacokinetic Testing , by Region USD Billion (2015-2020)
  • Table 10. Bioanalytical Testing Services Other Services , by Region USD Billion (2015-2020)
  • Table 11. Bioanalytical Testing Services: by Application(USD Billion)
  • Table 12. Bioanalytical Testing Services Oncology , by Region USD Billion (2015-2020)
  • Table 13. Bioanalytical Testing Services Immunology , by Region USD Billion (2015-2020)
  • Table 14. Bioanalytical Testing Services Neurology , by Region USD Billion (2015-2020)
  • Table 15. Bioanalytical Testing Services Hematology , by Region USD Billion (2015-2020)
  • Table 16. Bioanalytical Testing Services Others , by Region USD Billion (2015-2020)
  • Table 17. Bioanalytical Testing Services: by Molecule Type(USD Billion)
  • Table 18. Bioanalytical Testing Services Small Molecule , by Region USD Billion (2015-2020)
  • Table 19. Bioanalytical Testing Services Large Molecule [LC-MS Studies, Immunoassays, Others] , by Region USD Billion (2015-2020)
  • Table 20. South America Bioanalytical Testing Services, by Country USD Billion (2015-2020)
  • Table 21. South America Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 22. South America Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 23. South America Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 24. South America Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 25. Brazil Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 26. Brazil Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 27. Brazil Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 28. Brazil Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 29. Argentina Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 30. Argentina Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 31. Argentina Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 32. Argentina Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 33. Rest of South America Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 34. Rest of South America Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 35. Rest of South America Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 36. Rest of South America Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 37. Asia Pacific Bioanalytical Testing Services, by Country USD Billion (2015-2020)
  • Table 38. Asia Pacific Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 39. Asia Pacific Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 40. Asia Pacific Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 41. Asia Pacific Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 42. China Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 43. China Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 44. China Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 45. China Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 46. Japan Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 47. Japan Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 48. Japan Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 49. Japan Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 50. India Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 51. India Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 52. India Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 53. India Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 54. South Korea Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 55. South Korea Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 56. South Korea Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 57. South Korea Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 58. Australia Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 59. Australia Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 60. Australia Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 61. Australia Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 62. Rest of Asia-Pacific Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 63. Rest of Asia-Pacific Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 64. Rest of Asia-Pacific Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 65. Rest of Asia-Pacific Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 66. Europe Bioanalytical Testing Services, by Country USD Billion (2015-2020)
  • Table 67. Europe Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 68. Europe Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 69. Europe Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 70. Europe Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 71. Germany Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 72. Germany Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 73. Germany Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 74. Germany Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 75. Russia Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 76. Russia Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 77. Russia Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 78. Russia Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 79. France Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 80. France Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 81. France Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 82. France Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 83. Italy Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 84. Italy Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 85. Italy Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 86. Italy Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 87. United Kingdom Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 88. United Kingdom Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 89. United Kingdom Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 90. United Kingdom Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 91. Netherlands Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 92. Netherlands Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 93. Netherlands Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 94. Netherlands Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 95. Rest of Europe Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 96. Rest of Europe Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 97. Rest of Europe Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 98. Rest of Europe Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 99. MEA Bioanalytical Testing Services, by Country USD Billion (2015-2020)
  • Table 100. MEA Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 101. MEA Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 102. MEA Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 103. MEA Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 104. Middle East Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 105. Middle East Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 106. Middle East Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 107. Middle East Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 108. Africa Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 109. Africa Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 110. Africa Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 111. Africa Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 112. North America Bioanalytical Testing Services, by Country USD Billion (2015-2020)
  • Table 113. North America Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 114. North America Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 115. North America Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 116. North America Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 117. United States Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 118. United States Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 119. United States Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 120. United States Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 121. Canada Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 122. Canada Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 123. Canada Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 124. Canada Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 125. Mexico Bioanalytical Testing Services, by Type USD Billion (2015-2020)
  • Table 126. Mexico Bioanalytical Testing Services, by Application USD Billion (2015-2020)
  • Table 127. Mexico Bioanalytical Testing Services, by End User USD Billion (2015-2020)
  • Table 128. Mexico Bioanalytical Testing Services, by Molecule Type USD Billion (2015-2020)
  • Table 129. Bioanalytical Testing Services: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Bioanalytical Testing Services: by Type(USD Billion)
  • Table 144. Bioanalytical Testing Services Cell Based Assays [Bacterial, Viral] , by Region USD Billion (2021-2026)
  • Table 145. Bioanalytical Testing Services Virology Testing [In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays] , by Region USD Billion (2021-2026)
  • Table 146. Bioanalytical Testing Services Serology, Immunogenicity & Neutralizing Antibodies [Bacterial, Viral] , by Region USD Billion (2021-2026)
  • Table 147. Bioanalytical Testing Services Toxicology Services [In-Vitro Toxicology, In-Vivo Toxicology, Others] , by Region USD Billion (2021-2026)
  • Table 148. Bioanalytical Testing Services Biomarker Testing , by Region USD Billion (2021-2026)
  • Table 149. Bioanalytical Testing Services Metabolic Profiling and Mass Balance Studies , by Region USD Billion (2021-2026)
  • Table 150. Bioanalytical Testing Services Method Development Optimization and Validation , by Region USD Billion (2021-2026)
  • Table 151. Bioanalytical Testing Services Pharmacokinetic Testing , by Region USD Billion (2021-2026)
  • Table 152. Bioanalytical Testing Services Other Services , by Region USD Billion (2021-2026)
  • Table 153. Bioanalytical Testing Services: by Application(USD Billion)
  • Table 154. Bioanalytical Testing Services Oncology , by Region USD Billion (2021-2026)
  • Table 155. Bioanalytical Testing Services Immunology , by Region USD Billion (2021-2026)
  • Table 156. Bioanalytical Testing Services Neurology , by Region USD Billion (2021-2026)
  • Table 157. Bioanalytical Testing Services Hematology , by Region USD Billion (2021-2026)
  • Table 158. Bioanalytical Testing Services Others , by Region USD Billion (2021-2026)
  • Table 159. Bioanalytical Testing Services: by Molecule Type(USD Billion)
  • Table 160. Bioanalytical Testing Services Small Molecule , by Region USD Billion (2021-2026)
  • Table 161. Bioanalytical Testing Services Large Molecule [LC-MS Studies, Immunoassays, Others] , by Region USD Billion (2021-2026)
  • Table 162. South America Bioanalytical Testing Services, by Country USD Billion (2021-2026)
  • Table 163. South America Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 164. South America Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 165. South America Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 166. South America Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 167. Brazil Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 168. Brazil Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 169. Brazil Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 170. Brazil Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 171. Argentina Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 172. Argentina Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 173. Argentina Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 174. Argentina Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 175. Rest of South America Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 176. Rest of South America Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 177. Rest of South America Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 178. Rest of South America Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 179. Asia Pacific Bioanalytical Testing Services, by Country USD Billion (2021-2026)
  • Table 180. Asia Pacific Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 181. Asia Pacific Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 182. Asia Pacific Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 183. Asia Pacific Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 184. China Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 185. China Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 186. China Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 187. China Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 188. Japan Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 189. Japan Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 190. Japan Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 191. Japan Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 192. India Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 193. India Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 194. India Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 195. India Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 196. South Korea Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 197. South Korea Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 198. South Korea Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 199. South Korea Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 200. Australia Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 201. Australia Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 202. Australia Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 203. Australia Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 204. Rest of Asia-Pacific Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 205. Rest of Asia-Pacific Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 206. Rest of Asia-Pacific Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 207. Rest of Asia-Pacific Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 208. Europe Bioanalytical Testing Services, by Country USD Billion (2021-2026)
  • Table 209. Europe Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 210. Europe Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 211. Europe Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 212. Europe Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 213. Germany Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 214. Germany Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 215. Germany Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 216. Germany Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 217. Russia Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 218. Russia Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 219. Russia Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 220. Russia Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 221. France Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 222. France Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 223. France Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 224. France Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 225. Italy Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 226. Italy Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 227. Italy Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 228. Italy Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 229. United Kingdom Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 230. United Kingdom Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 231. United Kingdom Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 232. United Kingdom Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 233. Netherlands Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 234. Netherlands Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 235. Netherlands Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 236. Netherlands Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 237. Rest of Europe Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 238. Rest of Europe Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 239. Rest of Europe Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 240. Rest of Europe Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 241. MEA Bioanalytical Testing Services, by Country USD Billion (2021-2026)
  • Table 242. MEA Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 243. MEA Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 244. MEA Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 245. MEA Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 246. Middle East Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 247. Middle East Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 248. Middle East Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 249. Middle East Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 250. Africa Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 251. Africa Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 252. Africa Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 253. Africa Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 254. North America Bioanalytical Testing Services, by Country USD Billion (2021-2026)
  • Table 255. North America Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 256. North America Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 257. North America Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 258. North America Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 259. United States Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 260. United States Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 261. United States Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 262. United States Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 263. Canada Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 264. Canada Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 265. Canada Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 266. Canada Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 267. Mexico Bioanalytical Testing Services, by Type USD Billion (2021-2026)
  • Table 268. Mexico Bioanalytical Testing Services, by Application USD Billion (2021-2026)
  • Table 269. Mexico Bioanalytical Testing Services, by End User USD Billion (2021-2026)
  • Table 270. Mexico Bioanalytical Testing Services, by Molecule Type USD Billion (2021-2026)
  • Table 271. Bioanalytical Testing Services: by Type(USD/Units)
  • Table 272. Research Programs/Design for This Report
  • Table 273. Key Data Information from Secondary Sources
  • Table 274. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bioanalytical Testing Services: by Type USD Billion (2015-2020)
  • Figure 5. Global Bioanalytical Testing Services: by Application USD Billion (2015-2020)
  • Figure 6. Global Bioanalytical Testing Services: by Molecule Type USD Billion (2015-2020)
  • Figure 7. South America Bioanalytical Testing Services Share (%), by Country
  • Figure 8. Asia Pacific Bioanalytical Testing Services Share (%), by Country
  • Figure 9. Europe Bioanalytical Testing Services Share (%), by Country
  • Figure 10. MEA Bioanalytical Testing Services Share (%), by Country
  • Figure 11. North America Bioanalytical Testing Services Share (%), by Country
  • Figure 12. Global Bioanalytical Testing Services: by Type USD/Units (2015-2020)
  • Figure 13. Charles River Laboratories International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 14. Charles River Laboratories International Inc. (United States) Revenue: by Geography 2020
  • Figure 15. BioReliance Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 16. BioReliance Corporation (United States) Revenue: by Geography 2020
  • Figure 17. WuXi PharmaTech (Cayman) Inc. (China) Revenue, Net Income and Gross profit
  • Figure 18. WuXi PharmaTech (Cayman) Inc. (China) Revenue: by Geography 2020
  • Figure 19. Bioclin Research Laboratories (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Bioclin Research Laboratories (Ireland) Revenue: by Geography 2020
  • Figure 21. Eurofins Scientific SE (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 22. Eurofins Scientific SE (Luxembourg) Revenue: by Geography 2020
  • Figure 23. SGS (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. SGS (Switzerland) Revenue: by Geography 2020
  • Figure 25. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Merck Group (Germany) Revenue: by Geography 2020
  • Figure 27. LabCorp (United States) Revenue, Net Income and Gross profit
  • Figure 28. LabCorp (United States) Revenue: by Geography 2020
  • Figure 29. PPD Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. PPD Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Bioanalytical Technologies Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 32. Bioanalytical Technologies Private Limited (India) Revenue: by Geography 2020
  • Figure 33. Intertek Group Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Intertek Group Plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 35. PRA Health Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 36. PRA Health Sciences (United States) Revenue: by Geography 2020
  • Figure 37. Parexel International (United States) Revenue, Net Income and Gross profit
  • Figure 38. Parexel International (United States) Revenue: by Geography 2020
  • Figure 39. Global Bioanalytical Testing Services: by Type USD Billion (2021-2026)
  • Figure 40. Global Bioanalytical Testing Services: by Application USD Billion (2021-2026)
  • Figure 41. Global Bioanalytical Testing Services: by Molecule Type USD Billion (2021-2026)
  • Figure 42. South America Bioanalytical Testing Services Share (%), by Country
  • Figure 43. Asia Pacific Bioanalytical Testing Services Share (%), by Country
  • Figure 44. Europe Bioanalytical Testing Services Share (%), by Country
  • Figure 45. MEA Bioanalytical Testing Services Share (%), by Country
  • Figure 46. North America Bioanalytical Testing Services Share (%), by Country
  • Figure 47. Global Bioanalytical Testing Services: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Charles River Laboratories International Inc. (United States)
  • BioReliance Corporation (United States)
  • WuXi PharmaTech (Cayman) Inc. (China)
  • Bioclin Research Laboratories (Ireland)
  • Eurofins Scientific SE (Luxembourg)
  • SGS (Switzerland)
  • Merck Group (Germany)
  • LabCorp (United States)
  • PPD Inc. (United States)
  • Bioanalytical Technologies Private Limited (India)
  • Intertek Group Plc. (United Kingdom)
  • PRA Health Sciences (United States)
  • Parexel International (United States)
Additional players considered in the study are as follows:
Celerion (Switzerland) , Wieslab AB (Sweden) , Envigo (United Kingdom) , Bioagilytix Labs, LLC (United States) , Syneos Health (United States) , Icon PLC. (Ireland)
Select User Access Type

Key Highlights of Report


Jan 2022 222 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bioanalytical Testing Services Market Quantitative research analysis
Global Bioanalytical Testing Services Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Bioanalytical Testing Services market is expected to see a CAGR of 12.61% during projected year 2020 to 2026.
Top performing companies in the Global Bioanalytical Testing Services market are Charles River Laboratories International Inc. (United States), BioReliance Corporation (United States), WuXi PharmaTech (Cayman) Inc. (China), Bioclin Research Laboratories (Ireland), Eurofins Scientific SE (Luxembourg), SGS (Switzerland), Merck Group (Germany), LabCorp (United States), PPD Inc. (United States), Bioanalytical Technologies Private Limited (India), Intertek Group Plc. (United Kingdom), PRA Health Sciences (United States) and Parexel International (United States), to name a few.
North America is dominating the Bioanalytical Testing Services Market.

Know More About Global Bioanalytical Testing Services Market Report?

Have a Query? Click Here

Other Related Reports

Cerebrospinal Fluid Management Comprehensive Study by Application (Meningitis, Encephalitis, Neurosyphilis, Subarachnoid haemorrhage, Multiple sclerosis, Guillain-Barré syndrome, Meningeal carcinoma...
$ 3750
Neuroendoscopy Comprehensive Study by Type (Rigid Neuroendoscopes, Flexible Neuroendoscopes), Application (Transnasal, Intraventricular, Transcranial), Usability (Reusable, Disposable), End User (Hos...
$ 3650
Medical Automation Comprehensive Study by Type (Diagnostics & Monitoring, Medical Logistics & Training, Lab & Pharmacy Automation, Therapeutics), Medical Logistics & Training Automation (Logistics Au...
$ 3750
Medical Transport Services Comprehensive Study by Type (Medical Products, Incubator Transport, Mobile Treatment Facilities, Patient Transport), Application (Hospitals, Private Paying Customers, Nursi...
$ 3350
Compression Therapy Comprehensive Study by Type (Compression Stockings, Compression Bandages & Wraps, Compression Braces, Compression Pumps, Other), Application (Varicose Vein Treatment, Deep Vein Th...
$ 3750
Vascular Imaging Comprehensive Study by Application (Diagnostic, Therapeutic), Procedure (Coronary Angiography, Peripheral Angiography, Vascular Ultrasound, Cerebral Angiography, Microangiography, Ot...
$ 3750